Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/5086

TR 371 Rat Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                              TOLUENE


NTP Experiment-Test: 05701-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/18/94
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18




       Facility:  International Research and Development Corp.

       Chemical CAS #:  108883

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10           10           10                                                  
  Early Deaths                                                                                                                      
    Dead                                               6            7            6                                                  
    Moribund                                          11            8           14                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                32           35           30                                                  
    Dead                                               1                                                                            
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (49)         (50)         (49)                                                
      Inflammation, Chronic                                         1 (2%)                                                          
   Intestine Large, Cecum                             (50)         (49)         (49)                                                
      Inflammation, Acute                              1 (2%)       2 (4%)                                                          
   Intestine Large, Colon                             (50)         (49)         (49)                                                
      Inflammation, Acute                                           1 (2%)                                                          
      Parasite Metazoan                                5 (10%)      1 (2%)       2 (4%)                                             
   Intestine Large, Rectum                            (50)         (50)         (48)                                                
      Parasite Metazoan                                4 (8%)       5 (10%)                                                         
      Ulcer                                                         1 (2%)       1 (2%)                                             
   Intestine Small, Duodenum                          (50)         (49)         (49)                                                
      Edema                                                         1 (2%)                                                          
      Erosion                                          1 (2%)       1 (2%)       1 (2%)                                             
   Intestine Small, Ileum                             (50)         (49)         (49)                                                
      Edema                                                         1 (2%)                                                          
      Ulcer                                                         1 (2%)                                                          
   Intestine Small, Jejunum                           (50)         (49)         (49)                                                
      Edema                                                         1 (2%)                                                          
   Liver                                              (50)         (50)         (50)                                                
      Angiectasis                                      2 (4%)       6 (12%)      6 (12%)                                            
      Congestion                                                    1 (2%)                                                          
      Developmental Malformation                       6 (12%)      5 (10%)      5 (10%)                                            
      Fatty Change                                     3 (6%)       3 (6%)       2 (4%)                                             
      Focal Cellular Change                           29 (58%)     41 (82%)     41 (82%)                                            
      Granuloma                                       12 (24%)     13 (26%)     10 (20%)                                            
      Hematopoietic Cell Proliferation                 1 (2%)       2 (4%)       2 (4%)                                             
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Necrosis                                         4 (8%)       1 (2%)                                                          
      Arteriole, Thrombosis                            1 (2%)                                                                       
      Bile Duct, Hyperplasia                          38 (76%)     36 (72%)     31 (62%)                                            
      Portal, Hyperplasia                                                        1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Portal, Inflammation, Chronic                   47 (94%)     46 (92%)     40 (80%)                                            
      Portal, Inflammation, Chronic Active                                       1 (2%)                                             
      Venule, Thrombosis                               1 (2%)                                                                       
   Mesentery                                          (1)          (1)          (2)                                                 
      Fat, Necrosis                                    1 (100%)     1 (100%)     1 (50%)                                            
   Pancreas                                           (50)         (49)         (50)                                                
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)                                             
      Acinus, Atrophy                                 18 (36%)     24 (49%)     15 (30%)                                            
      Acinus, Hyperplasia                              1 (2%)       4 (8%)                                                          
      Acinus, Vacuolization Cytoplasmic                                          1 (2%)                                             
      Arteriole, Inflammation, Chronic                                           1 (2%)                                             
      Duct, Ectasia                                    1 (2%)                                                                       
   Salivary Glands                                    (50)         (50)         (50)                                                
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Acinus, Atrophy                                                            1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (50)                                                
      Hyperkeratosis                                                1 (2%)                                                          
      Hyperplasia, Squamous                            1 (2%)       2 (4%)       4 (8%)                                             
      Inflammation, Acute                                           3 (6%)                                                          
      Inflammation, Chronic Active                     2 (4%)       1 (2%)       3 (6%)                                             
      Ulcer                                            6 (12%)      5 (10%)      9 (18%)                                            
   Stomach, Glandular                                 (50)         (50)         (50)                                                
      Foreign Body                                                               1 (2%)                                             
      Inflammation, Acute                                           1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                                               2 (4%)                                             
      Mucosa, Dilatation                              27 (54%)     26 (52%)     28 (56%)                                            
      Mucosa, Erosion                                  6 (12%)      4 (8%)       5 (10%)                                            
      Mucosa, Mineralization                                                     1 (2%)                                             
      Mucosa, Pigmentation                             1 (2%)                                                                       
      Mucosa, Ulcer                                    2 (4%)                                                                       
      Serosa, Inflammation, Chronic Active                                       1 (2%)                                             
   Tooth                                                           (1)          (2)                                                 
      Peridontal Tissue, Inflammation, Chronic                                   1 (50%)                                            
      Pulp, Inflammation, Chronic                                                1 (50%)                                            
      Pulp, Inflammation, Chronic Active                            1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)                                                
      Aorta, Mineralization                                                      1 (2%)                                             
   Heart                                              (50)         (50)         (50)                                                
      Cardiomyopathy, Chronic                         48 (96%)     50 (100%)    47 (94%)                                            
      Inflammation, Acute                              1 (2%)                                                                       
      Mineralization                                   1 (2%)                    1 (2%)                                             
      Artery, Mineralization                                                     1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Atrium, Thrombosis                               2 (4%)       1 (2%)       1 (2%)                                             
      Ventricle, Thrombosis                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (49)         (49)                                                
      Congestion                                                                 1 (2%)                                             
      Degeneration, Fatty                             33 (66%)     31 (63%)     37 (76%)                                            
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia                                     16 (32%)     19 (39%)      9 (18%)                                            
      Hypertrophy                                      4 (8%)       9 (18%)      4 (8%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Pigmentation                                    50 (100%)    48 (98%)     48 (98%)                                            
   Adrenal Gland, Medulla                             (49)         (48)         (49)                                                
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hyperplasia                                      4 (8%)       4 (8%)       6 (12%)                                            
   Islets, Pancreatic                                 (50)         (49)         (50)                                                
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
   Parathyroid Gland                                  (42)         (44)         (41)                                                
      Hypertrophy                                                                1 (2%)                                             
   Pituitary Gland                                    (50)         (50)         (50)                                                
      Pars Distalis, Angiectasis                       1 (2%)       3 (6%)       1 (2%)                                             
      Pars Distalis, Congestion                                                  1 (2%)                                             
      Pars Distalis, Cyst                             10 (20%)     14 (28%)     11 (22%)                                            
      Pars Distalis, Hemorrhage                        3 (6%)                    1 (2%)                                             
      Pars Distalis, Hyperplasia                       7 (14%)     17 (34%)      7 (14%)                                            
      Pars Distalis, Metaplasia, Osseous                            1 (2%)                                                          
      Pars Intermedia, Angiectasis                     1 (2%)       2 (4%)       2 (4%)                                             
      Pars Intermedia, Cyst                            1 (2%)                                                                       
      Pars Nervosa, Cyst                                            1 (2%)                                                          
   Thyroid Gland                                      (50)         (50)         (50)                                                
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Acute                              1 (2%)                                                                       
      Ultimobranchial Cyst                                          1 (2%)       2 (4%)                                             
      C-Cell, Hyperplasia                             17 (34%)     23 (46%)     15 (30%)                                            
      Follicle, Ectasia                                             4 (8%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (49)         (50)         (44)                                                
      Cyst                                             1 (2%)                                                                       
      Hyperplasia                                                   2 (4%)       2 (5%)                                             
      Inflammation, Acute                              1 (2%)                    2 (5%)                                             
      Inflammation, Chronic                           21 (43%)     20 (40%)     21 (48%)                                            
      Inflammation, Chronic Active                    10 (20%)     14 (28%)      7 (16%)                                            
      Duct, Ectasia                                    2 (4%)                    1 (2%)                                             
      Duct, Hyperplasia, Squamous                                                1 (2%)                                             
   Ovary                                              (50)         (50)         (50)                                                
      Follicle, Cyst                                                             1 (2%)                                             
      Periovarian Tissue, Cyst                         2 (4%)       1 (2%)       2 (4%)                                             
   Uterus                                             (50)         (50)         (50)                                                
      Ectasia                                          2 (4%)       1 (2%)       1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Prolapse                                         1 (2%)                                                                       
      Endometrium, Ectasia                                                       1 (2%)                                             
      Endometrium, Hyperplasia, Cystic                 2 (4%)       2 (4%)       7 (14%)                                            
      Endometrium, Inflammation, Chronic                            1 (2%)       1 (2%)                                             
      Myometrium, Inflammation, Chronic                                          1 (2%)                                             
   Vagina                                             (4)          (4)          (3)                                                 
      Inflammation, Acute                                                        1 (33%)                                            
      Inflammation, Chronic Active                     1 (25%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (50)         (50)                                                
      Hyperplasia                                                                1 (2%)                                             
      Myelofibrosis                                    8 (16%)      9 (18%)      4 (8%)                                             
      Myeloid Cell, Hyperplasia                        1 (2%)                                                                       
   Lymph Node                                         (50)         (50)         (50)                                                
      Congestion                                       1 (2%)       1 (2%)       1 (2%)                                             
      Hyperplasia, Lymphoid                            6 (12%)      3 (6%)      10 (20%)                                            
      Inflammation, Acute                              1 (2%)                    1 (2%)                                             
      Pigmentation                                                  1 (2%)                                                          
      Mediastinal, Congestion                                       1 (2%)                                                          
      Mediastinal, Hemorrhage                          1 (2%)                                                                       
      Mediastinal, Hyperplasia, Lymphoid                            1 (2%)       2 (4%)                                             
      Mediastinal, Pigmentation                                                  1 (2%)                                             
      Mesenteric, Congestion                           4 (8%)       3 (6%)       4 (8%)                                             
      Mesenteric, Edema                                1 (2%)                                                                       
      Mesenteric, Hyperplasia, Lymphoid               17 (34%)     32 (64%)     29 (58%)                                            
      Mesenteric, Inflammation, Acute                  1 (2%)       1 (2%)                                                          
      Renal, Congestion                                             1 (2%)                                                          
   Lymph Node, Mandibular                             (47)         (48)         (42)                                                
      Congestion                                       5 (11%)      8 (17%)      3 (7%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Cyst                                             1 (2%)       1 (2%)       2 (5%)                                             
      Hyperplasia, Lymphoid                           41 (87%)     42 (88%)     39 (93%)                                            
      Inflammation, Acute                              1 (2%)                    1 (2%)                                             
   Spleen                                             (50)         (50)         (50)                                                
      Fibrosis                                                      3 (6%)       3 (6%)                                             
      Hematopoietic Cell Proliferation                41 (82%)     46 (92%)     44 (88%)                                            
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)       1 (2%)                                             
      Hyperplasia, Reticulum Cell                      1 (2%)                                                                       
      Infarct                                                       1 (2%)       1 (2%)                                             
      Pigmentation                                    44 (88%)     44 (88%)     47 (94%)                                            
      Capsule, Fibrosis                                             2 (4%)                                                          
      Capsule, Inflammation, Acute                                               1 (2%)                                             
   Thymus                                             (46)         (46)         (46)                                                
      Congestion                                       4 (9%)       2 (4%)       1 (2%)                                             
      Cyst                                             2 (4%)       2 (4%)       3 (7%)                                             
      Hyperplasia, Lymphoid                                         3 (7%)       1 (2%)                                             
      Mediastinum, Inflammation, Chronic Active        1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)                                                
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Acinus, Ectasia                                 37 (74%)     34 (68%)     27 (54%)                                            
      Acinus, Hyperplasia                              3 (6%)       1 (2%)                                                          
      Acinus, Hyperplasia, Cystic                                                1 (2%)                                             
      Duct, Ectasia                                   21 (42%)     31 (62%)     23 (46%)                                            
   Skin                                               (50)         (50)         (50)                                                
      Cyst Epithelial Inclusion                                                  1 (2%)                                             
      Head, Inflammation, Chronic Active               1 (2%)       1 (2%)                                                          
      Head, Ulcer                                                                1 (2%)                                             
      Lip, Inflammation, Chronic Active                             1 (2%)                                                          
      Subcutaneous Tissue, Abscess                                               1 (2%)                                             
      Subcutaneous Tissue, Head, Abscess                                         1 (2%)                                             
      Subcutaneous Tissue, Head, Granuloma                          1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (50)         (50)                                                
      Cranium, Fibrous Osteodystrophy                  1 (2%)                    2 (4%)                                             
      Cranium, Osteopetrosis                           2 (4%)       1 (2%)                                                          
      Femur, Fibrous Osteodystrophy                    1 (2%)                    4 (8%)                                             
      Femur, Osteopetrosis                             3 (6%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (49)                                                
      Compression                                     11 (22%)      6 (12%)     13 (27%)                                            
      Gliosis                                          1 (2%)                                                                       
      Hemorrhage                                       5 (10%)      6 (12%)      3 (6%)                                             
      Hydrocephalus                                    1 (2%)       2 (4%)                                                          
      Lateral Ventricle, Hemorrhage                    1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Congestion                                       5 (10%)      5 (10%)      6 (12%)                                            
      Hemorrhage                                       7 (14%)      7 (14%)      4 (8%)                                             
      Infiltration Cellular                                         1 (2%)                                                          
      Infiltration Cellular, Lymphocyte               49 (98%)     49 (98%)     50 (100%)                                           
      Metaplasia, Osseous                                           1 (2%)                                                          
      Pigmentation, Cholesterol                        1 (2%)                    2 (4%)                                             
      Alveolar Epithelium, Hyperplasia                              1 (2%)       2 (4%)                                             
      Alveolus, Infiltration Cellular, Histiocyte     28 (56%)     20 (40%)     36 (72%)                                            
      Alveolus, Mineralization                         1 (2%)                                                                       
      Arteriole, Mineralization                       25 (50%)     30 (60%)     26 (52%)                                            
      Interstitium, Inflammation, Chronic             17 (34%)      9 (18%)      2 (4%)                                             
      Interstitium, Inflammation, Chronic Active       1 (2%)       2 (4%)       4 (8%)                                             
      Peribronchiolar, Inflammation, Acute             2 (4%)       1 (2%)                                                          
      Peribronchiolar, Inflammation, Chronic                        5 (10%)      1 (2%)                                             
      Peribronchiolar, Inflammation, Chronic Active                              1 (2%)                                             
      Pleura, Fibrosis                                                           1 (2%)                                             
      Smooth Muscle, Hyperplasia                                                 1 (2%)                                             
   Nose                                               (49)         (50)         (50)                                                
      Glands, Hyperplasia                                                        1 (2%)                                             
      Lumen, Foreign Body                              4 (8%)       1 (2%)       1 (2%)                                             
      Lumen, Hemorrhage                               30 (61%)     34 (68%)     32 (64%)                                            
      Mucosa, Inflammation                                          1 (2%)                                                          
      Mucosa, Inflammation, Acute                     27 (55%)     41 (82%)     41 (82%)                                            
      Nasolacrimal Duct, Hemorrhage                    1 (2%)                                                                       
      Nasolacrimal Duct, Inflammation, Acute           5 (10%)      2 (4%)       6 (12%)                                            
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
          Active                                                    1 (2%)                                                          
      Olfactory Epithelium, Degeneration              44 (90%)     48 (96%)     47 (94%)                                            
      Olfactory Epithelium, Erosion                    2 (4%)      11 (22%)     10 (20%)                                            
      Olfactory Epithelium, Hemorrhage                                           1 (2%)                                             
      Olfactory Epithelium, Metaplasia                              1 (2%)       5 (10%)                                            
      Olfactory Epithelium, Metaplasia, Squamous                    1 (2%)       1 (2%)                                             
      Respiratory Epithelium, Degeneration            29 (59%)     45 (90%)     39 (78%)                                            
      Respiratory Epithelium, Erosion                  4 (8%)       1 (2%)       3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Respiratory Epithelium, Metaplasia, Squamous     1 (2%)       1 (2%)                                                          
   Trachea                                            (50)         (50)         (50)                                                
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic Active                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (5)          (4)          (3)                                                 
      Atrophy                                          1 (20%)      1 (25%)                                                         
      Cataract                                         3 (60%)      2 (50%)      2 (67%)                                            
      Hemorrhage                                                    1 (25%)                                                         
      Anterior Chamber, Hemorrhage                                               1 (33%)                                            
      Lids, Inflammation, Chronic Active                                         1 (33%)                                            
      Retina, Degeneration                             4 (80%)      3 (75%)      2 (67%)                                            
      Sclera, Mineralization                           2 (40%)      2 (50%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)                                                
      Hydronephrosis                                                             1 (2%)                                             
      Inflammation, Acute                              1 (2%)                                                                       
      Nephropathy, Chronic                            49 (98%)     48 (96%)     49 (98%)                                            
      Capsule, Inflammation, Chronic                                             1 (2%)                                             
      Pelvis, Calculus Micro Observation Only          1 (2%)       1 (2%)                                                          
      Renal Tubule, Cyst                               2 (4%)                    1 (2%)                                             
      Renal Tubule, Hyperplasia                        1 (2%)       1 (2%)                                                          
      Renal Tubule, Hypertrophy                                     1 (2%)                                                          
      Renal Tubule, Pigmentation                      49 (98%)     50 (100%)    48 (96%)                                            
   Urinary Bladder                                    (50)         (50)         (50)                                                
      Infiltration Cellular, Lymphocyte                1 (2%)                    1 (2%)                                             
      Inflammation, Chronic                            1 (2%)                    2 (4%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10           10           10                                                  
  Early Deaths                                                                                                                      
    Moribund                                          14           11           23                                                  
    Dead                                               6            8            5                                                  
    Natural Death                                                   3                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                29           27           22                                                  
    Dead                                                            1                                                               
    Accident                                           1                                                                            
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (50)         (50)         (49)                                                
      Erosion                                                       1 (2%)                                                          
      Hemorrhage                                                    2 (4%)                                                          
      Inflammation, Acute                              1 (2%)                                                                       
   Intestine Large, Colon                             (50)         (50)         (49)                                                
      Granuloma                                                                  1 (2%)                                             
      Parasite Metazoan                                2 (4%)       4 (8%)       1 (2%)                                             
   Intestine Large, Rectum                            (49)         (50)         (49)                                                
      Erosion                                                       1 (2%)                                                          
      Inflammation, Acute                                                        1 (2%)                                             
      Parasite Metazoan                                2 (4%)       4 (8%)       7 (14%)                                            
      Ulcer                                                         4 (8%)       3 (6%)                                             
   Intestine Small, Duodenum                          (50)         (50)         (49)                                                
      Erosion                                                                    1 (2%)                                             
      Ulcer                                            1 (2%)                                                                       
   Intestine Small, Ileum                             (49)         (50)         (49)                                                
      Erosion                                                                    1 (2%)                                             
   Liver                                              (50)         (50)         (50)                                                
      Angiectasis                                      7 (14%)     11 (22%)      3 (6%)                                             
      Congestion                                       3 (6%)       2 (4%)       1 (2%)                                             
      Developmental Malformation                       1 (2%)       4 (8%)       2 (4%)                                             
      Fatty Change                                     3 (6%)       2 (4%)       8 (16%)                                            
      Focal Cellular Change                           28 (56%)     23 (46%)     23 (46%)                                            
      Granuloma                                        1 (2%)       1 (2%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                              2 (4%)                                                          
      Hemorrhage                                                    2 (4%)                                                          
      Necrosis                                         2 (4%)       2 (4%)       1 (2%)                                             
      Bile Duct, Dilatation                                         1 (2%)                                                          
      Bile Duct, Hyperplasia                          48 (96%)     49 (98%)     49 (98%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Bile Duct, Inflammation, Chronic                              1 (2%)                                                          
      Portal, Inflammation, Chronic                   48 (96%)     45 (90%)     46 (92%)                                            
      Serosa, Fibrosis                                                           1 (2%)                                             
   Mesentery                                          (2)          (2)          (4)                                                 
      Inflammation, Acute                                           1 (50%)                                                         
      Arteriole, Inflammation, Chronic                                           2 (50%)                                            
      Arteriole, Inflammation, Chronic Active                                    1 (25%)                                            
      Fat, Necrosis                                    2 (100%)                  1 (25%)                                            
   Pancreas                                           (50)         (50)         (50)                                                
      Inflammation, Acute                                           1 (2%)                                                          
      Acinus, Atrophy                                 30 (60%)     34 (68%)     30 (60%)                                            
      Acinus, Hyperplasia                              1 (2%)       4 (8%)       1 (2%)                                             
      Arteriole, Inflammation, Chronic Active                                    1 (2%)                                             
      Arteriole, Mineralization                                                  1 (2%)                                             
      Artery, Inflammation, Chronic                    1 (2%)                                                                       
   Salivary Glands                                    (50)         (50)         (50)                                                
      Infiltration Cellular, Lymphocyte                1 (2%)       1 (2%)                                                          
      Inflammation, Chronic                                         1 (2%)                                                          
      Acinus, Atrophy                                               1 (2%)       1 (2%)                                             
      Arteriole, Mineralization                                                  1 (2%)                                             
   Stomach                                            (50)         (50)         (50)                                                
      Ulcer                                                                      1 (2%)                                             
   Stomach, Forestomach                               (50)         (50)         (49)                                                
      Cyst                                             1 (2%)                                                                       
      Erosion                                          1 (2%)       1 (2%)       1 (2%)                                             
      Hyperplasia, Squamous                            2 (4%)       1 (2%)       2 (4%)                                             
      Inflammation, Acute                              4 (8%)       3 (6%)       2 (4%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Chronic Active                     3 (6%)       2 (4%)       2 (4%)                                             
      Mineralization                                                             1 (2%)                                             
      Ulcer                                            4 (8%)       7 (14%)      9 (18%)                                            
   Stomach, Glandular                                 (50)         (50)         (49)                                                
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic Active                                               1 (2%)                                             
      Mineralization                                                             2 (4%)                                             
      Mucosa, Congestion                                            1 (2%)                                                          
      Mucosa, Dilatation                              17 (34%)     21 (42%)     18 (37%)                                            
      Mucosa, Ectasia                                  2 (4%)                                                                       
      Mucosa, Erosion                                  4 (8%)      11 (22%)      9 (18%)                                            
      Mucosa, Granuloma                                             1 (2%)                                                          
      Mucosa, Hemorrhage                                            1 (2%)                                                          
      Mucosa, Inflammation, Acute                                   1 (2%)                                                          
      Mucosa, Ulcer                                    2 (4%)       5 (10%)      3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (50)         (50)                                                
      Aorta, Mineralization                                                      1 (2%)                                             
      Thoracic, Inflammation, Chronic Active                                     1 (2%)                                             
   Heart                                              (50)         (50)         (50)                                                
      Cardiomyopathy, Chronic                         49 (98%)     47 (94%)     47 (94%)                                            
      Hemorrhage                                                    1 (2%)                                                          
      Mineralization                                                             1 (2%)                                             
      Artery, Mineralization                                                     1 (2%)                                             
      Atrium, Thrombosis                                            6 (12%)      3 (6%)                                             
      Pericardium, Inflammation, Chronic                            1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)         (50)                                                
      Degeneration, Fatty                             35 (70%)     41 (82%)     43 (86%)                                            
      Hyperplasia                                     15 (30%)     10 (20%)     11 (22%)                                            
      Hypertrophy                                      4 (8%)       5 (10%)      3 (6%)                                             
      Pigmentation                                    43 (86%)     46 (92%)     39 (78%)                                            
   Adrenal Gland, Medulla                             (49)         (50)         (50)                                                
      Hyperplasia                                     10 (20%)     15 (30%)      4 (8%)                                             
   Islets, Pancreatic                                 (50)         (50)         (50)                                                
      Hyperplasia                                      1 (2%)       4 (8%)       3 (6%)                                             
   Parathyroid Gland                                  (42)         (45)         (44)                                                
      Hyperplasia                                      2 (5%)       1 (2%)       1 (2%)                                             
      Hypertrophy                                                   2 (4%)                                                          
   Pituitary Gland                                    (49)         (50)         (50)                                                
      Pars Distalis, Angiectasis                                    3 (6%)       1 (2%)                                             
      Pars Distalis, Atrophy                           1 (2%)                                                                       
      Pars Distalis, Cyst                              3 (6%)       6 (12%)      5 (10%)                                            
      Pars Distalis, Hemorrhage                        1 (2%)                    1 (2%)                                             
      Pars Distalis, Hyperplasia                      18 (37%)     22 (44%)     11 (22%)                                            
      Pars Intermedia, Angiectasis                                  2 (4%)       1 (2%)                                             
      Pars Intermedia, Cyst                            2 (4%)       2 (4%)       1 (2%)                                             
      Pars Intermedia, Hyperplasia                                  2 (4%)                                                          
      Pars Nervosa, Pigmentation                       1 (2%)                                                                       
   Thyroid Gland                                      (50)         (50)         (50)                                                
      Infiltration Cellular, Lymphocyte                1 (2%)                    1 (2%)                                             
      Ultimobranchial Cyst                             1 (2%)                    2 (4%)                                             
      C-Cell, Hyperplasia                             12 (24%)     20 (40%)     14 (28%)                                            
      Follicle, Ectasia                                3 (6%)       2 (4%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Preputial Gland                                    (50)         (50)         (50)                                                
      Abscess                                          3 (6%)                                                                       
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic                           29 (58%)     28 (56%)     22 (44%)                                            
      Inflammation, Chronic Active                    10 (20%)     17 (34%)     25 (50%)                                            
      Mineralization                                                             1 (2%)                                             
      Duct, Ectasia                                    1 (2%)                    2 (4%)                                             
   Prostate                                           (50)         (50)         (50)                                                
      Atrophy                                          1 (2%)                                                                       
      Hyperplasia                                     10 (20%)      3 (6%)       3 (6%)                                             
      Inflammation, Acute                              7 (14%)      7 (14%)      5 (10%)                                            
      Inflammation, Chronic                            1 (2%)       3 (6%)       2 (4%)                                             
      Inflammation, Chronic Active                    14 (28%)      6 (12%)     10 (20%)                                            
   Seminal Vesicle                                                 (5)                                                              
      Dilatation                                                    1 (20%)                                                         
   Testes                                             (50)         (50)         (50)                                                
      Atrophy                                         11 (22%)     12 (24%)      9 (18%)                                            
      Congestion                                                    1 (2%)                                                          
      Mineralization                                                2 (4%)                                                          
      Arteriole, Inflammation, Chronic                              2 (4%)       1 (2%)                                             
      Interstitial Cell, Hyperplasia                  35 (70%)     46 (92%)     37 (74%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (50)                                                
      Myelofibrosis                                    3 (6%)       1 (2%)       5 (10%)                                            
   Lymph Node                                         (50)         (50)         (50)                                                
      Congestion                                                    1 (2%)                                                          
      Edema                                            1 (2%)                                                                       
      Hyperplasia, Lymphoid                            1 (2%)       2 (4%)                                                          
      Mediastinal, Congestion                          1 (2%)       5 (10%)                                                         
      Mediastinal, Hemorrhage                                                    1 (2%)                                             
      Mediastinal, Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                             
      Mesenteric, Congestion                           1 (2%)       1 (2%)       4 (8%)                                             
      Mesenteric, Hyperplasia, Lymphoid               17 (34%)     20 (40%)     22 (44%)                                            
      Mesenteric, Inflammation, Acute                               1 (2%)                                                          
      Popliteal, Hyperplasia, Lymphoid                                           1 (2%)                                             
   Lymph Node, Mandibular                             (36)         (45)         (37)                                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Congestion                                      10 (28%)     10 (22%)      3 (8%)                                             
      Cyst                                             1 (3%)       1 (2%)       1 (3%)                                             
      Hyperplasia, Lymphoid                           32 (89%)     31 (69%)     30 (81%)                                            
   Spleen                                             (50)         (50)         (50)                                                
      Fibrosis                                         5 (10%)      3 (6%)       4 (8%)                                             
      Hematopoietic Cell Proliferation                42 (84%)     42 (84%)     40 (80%)                                            
      Hyperplasia, Lymphoid                            2 (4%)                    3 (6%)                                             
      Infarct                                                       1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Pigmentation                                    39 (78%)     37 (74%)     42 (84%)                                            
   Thymus                                             (44)         (46)         (46)                                                
      Congestion                                       2 (5%)       5 (11%)      1 (2%)                                             
      Cyst                                             4 (9%)       1 (2%)                                                          
      Hyperplasia, Lymphoid                                         4 (9%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (48)         (49)                                                
      Inflammation, Acute                              2 (4%)                                                                       
      Inflammation, Chronic                            1 (2%)                                                                       
      Acinus, Ectasia                                 34 (68%)     25 (52%)     28 (57%)                                            
      Duct, Ectasia                                   10 (20%)     19 (40%)      8 (16%)                                            
   Skin                                               (50)         (50)         (50)                                                
      Abscess                                                       1 (2%)       1 (2%)                                             
      Cyst Epithelial Inclusion                        1 (2%)       2 (4%)                                                          
      Epidermis, Cyst                                  1 (2%)                                                                       
      Foot, Ulcer                                                                1 (2%)                                             
      Hair Follicle, Inflammation, Chronic                          1 (2%)                                                          
      Hair Follicle, Head, Hemorrhage                  1 (2%)                                                                       
      Hair Follicle, Head, Inflammation, Acute         1 (2%)                                                                       
      Head, Abscess                                                              1 (2%)                                             
      Head, Inflammation, Acute                        1 (2%)       1 (2%)       1 (2%)                                             
      Head, Inflammation, Chronic Active               1 (2%)                                                                       
      Subcutaneous Tissue, Edema                                    1 (2%)                                                          
      Subcutaneous Tissue, Hemorrhage                               1 (2%)                                                          
      Tail, Inflammation, Chronic Active               1 (2%)                                                                       
      Tail, Subcutaneous Tissue, Inflammation,                                                                                      
           Acute                                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)                                                
      Cranium, Abscess                                              1 (2%)                                                          
      Cranium, Fibrous Osteodystrophy                  1 (2%)       1 (2%)       2 (4%)                                             
      Cranium, Inflammation, Chronic                                             1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
      Femur, Fibrous Osteodystrophy                    1 (2%)       4 (8%)       2 (4%)                                             
      Humerus, Fracture                                                          1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)                                                
      Compression                                      5 (10%)      7 (14%)      6 (12%)                                            
      Hemorrhage                                      11 (22%)      8 (16%)      2 (4%)                                             
      Necrosis                                         1 (2%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Congestion                                       6 (12%)      3 (6%)       4 (8%)                                             
      Hemorrhage                                       8 (16%)      4 (8%)       5 (10%)                                            
      Infiltration Cellular, Lymphocyte               50 (100%)    47 (94%)     49 (98%)                                            
      Inflammation, Chronic                                                      1 (2%)                                             
      Metaplasia, Osseous                                                        1 (2%)                                             
      Pigmentation, Cholesterol                        1 (2%)       2 (4%)       2 (4%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (4%)       2 (4%)       3 (6%)                                             
      Alveolus, Infiltration Cellular, Histiocyte     26 (52%)     18 (36%)     25 (50%)                                            
      Alveolus, Mineralization                                                   2 (4%)                                             
      Arteriole, Mineralization                       41 (82%)     40 (80%)     38 (76%)                                            
      Bronchiole, Inflammation, Acute                                            2 (4%)                                             
      Bronchiole, Mineralization                       1 (2%)                                                                       
      Interstitium, Inflammation, Chronic              5 (10%)      6 (12%)     10 (20%)                                            
      Interstitium, Inflammation, Chronic Active       5 (10%)                   2 (4%)                                             
      Peribronchiolar, Inflammation, Chronic                        3 (6%)                                                          
      Peribronchiolar, Inflammation, Chronic Active                 1 (2%)                                                          
      Pleura, Inflammation, Chronic Active             1 (2%)                                                                       
   Nose                                               (50)         (50)         (49)                                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Lumen, Degeneration                                                        1 (2%)                                             
      Lumen, Foreign Body                              4 (8%)       5 (10%)      2 (4%)                                             
      Lumen, Hemorrhage                               31 (62%)     25 (50%)     35 (71%)                                            
      Mucosa, Hemorrhage                                            1 (2%)                                                          
      Mucosa, Inflammation, Acute                     30 (60%)     30 (60%)     40 (82%)                                            
      Mucosa, Inflammation, Chronic Active             1 (2%)                                                                       
      Nasolacrimal Duct, Degeneration                               1 (2%)                                                          
      Nasolacrimal Duct, Inflammation                  1 (2%)                                                                       
      Nasolacrimal Duct, Inflammation, Acute           4 (8%)       1 (2%)       2 (4%)                                             
      Nasopharyngeal Duct, Inflammation, Acute         1 (2%)                                                                       
      Olfactory Epithelium, Degeneration              39 (78%)     48 (96%)     42 (86%)                                            
      Olfactory Epithelium, Erosion                                 3 (6%)       8 (16%)                                            
      Olfactory Epithelium, Metaplasia                              1 (2%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05701-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              TOLUENE                                          Date: 09/18/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:13:18  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 PPM        600 PPM      1200 PPM                                               
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Olfactory Epithelium, Metaplasia, Squamous                                 2 (4%)                                             
      Respiratory Epithelium, Degeneration            15 (30%)     37 (74%)     31 (63%)                                            
      Respiratory Epithelium, Erosion                  4 (8%)       6 (12%)      3 (6%)                                             
      Respiratory Epithelium, Hemorrhage                            1 (2%)                                                          
      Respiratory Epithelium, Metaplasia, Squamous     1 (2%)       1 (2%)                                                          
      Respiratory Epithelium, Ulcer                                              1 (2%)                                             
      Vomeronasal Organ, Inflammation, Acute           1 (2%)                    1 (2%)                                             
   Trachea                                            (50)         (50)         (50)                                                
      Inflammation, Acute                                           1 (2%)       3 (6%)                                             
      Inflammation, Chronic Active                                  3 (6%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)                       (2)                                                 
      Cataract                                         1 (50%)                   2 (100%)                                           
      Retina, Degeneration                             1 (50%)                   1 (50%)                                            
      Sclera, Mineralization                           1 (50%)                   2 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)                                                
      Congestion                                                    1 (2%)                                                          
      Infarct                                                                    2 (4%)                                             
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Mineralization                                                             1 (2%)                                             
      Nephropathy, Chronic                            49 (98%)     48 (96%)     48 (96%)                                            
      Pelvis, Inflammation, Acute                                   1 (2%)       1 (2%)                                             
      Renal Tubule, Cyst                               1 (2%)       2 (4%)       5 (10%)                                            
      Renal Tubule, Hyperplasia                        4 (8%)       4 (8%)                                                          
      Renal Tubule, Pigmentation                      50 (100%)    48 (96%)     47 (94%)                                            
   Urinary Bladder                                    (50)         (50)         (50)                                                
      Calculus Gross Observation                       1 (2%)                                                                       
      Calculus Micro Observation Only                               1 (2%)                                                          
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)       1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       2 (4%)                                             
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 104895-104895/104895


--multipart-boundary--